Evidence map›Paper›PMID 36575345›Full record

ArticleJournal of cancer research and clinical oncology2023

The basement membrane-related gene signature is associated with immunity and predicts survival accurately in hepatocellular carcinoma.

Yu Zhao, Zhenjie Yin, Kangming Huang, Fajing Zhang, Yun Chen, Yinghan Deng, Hongbin Chen

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yu ZhaoDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Zhenjie YinDepartment of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Kangming HuangDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Fajing ZhangDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Yun ChenDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Yinghan DengDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Hongbin ChenDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China. smchb2008@qq.com.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsHepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Expression defects and turnover of basement membrane (BM) proteins are key pathogenic factors in cancer. It is still uncertain how the expression of BM-related genes (BMGs) in HCC relates to prognosis.

methodsAll of the HCC cohort's RNA-seq and clinical information came from TCGA datasets. The least absolute shrinkage and selection operator (LASSO) regression algorithm was utilized to filter down the candidate genes and construct the prognostic model. Univariate and multivariate Cox analyses were run to examine if the risk score may serve as a standalone prognostic indicator. The single-sample gene set enrichment analysis (ssGSEA) was utilized to analyze examine immune cell infiltration and pathway activity.

resultsFive genes and their risk coefficients were eventually identified and patients with HCC were classified as either high or low risk based on the median of risk scores. Multivariate Cox regression analysis found a significant correlation between risk score and OS (p < 0.001). Subgroup analysis showed that BMGs signature had good prediction ability for HCC patients in age, gender, T stage, and AJCC stage (all p < 0.05). According to the ssGSEA, the high-risk subgroup showed higher levels of immune cell infiltration and immune-related pathways were more engaged in the high-risk group.

conclusionsOur research systematically built a prognostic model using risk score based on BMGs signature in HCC patients. The immune feature analysis of the BMGs signature indicated a potential regulation between tumor immunity and BM in HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAlgorithmsBasement MembraneHumansMembrane ProteinsPrognosisRisk FactorsMembrane ProteinsBasement membraneExtracellular matrixHepatocellular carcinomaPrediction modelTumor microenvironment

Identifiers

PMID36575345
PMCPMC11796773
OpenAlexW4313236792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.